Abstract
BackgroundThe identification of new complementary diagnostic markers to RF and anti-CCP is a clinical imperative since a substantial proportion of patients are seronegative, especially in early disease when access to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have